Cytomegalovirus (CMV) infection remains a major cause of morbidity and mortality among patients receiving allogeneic bone marrow transplantation. Pneumonia is the most serious manifestation, with an incidence of 15% to 30%. Although the use of ganciclovir with intravenous immunoglobulin has improved survival, CMV pneumonitis is often fatal, underscoring the need for effective prophylaxis.
|Journal||Infections in Medicine|
|State||Published - 1994|
- cytomegalovirus (CMV)